STX vs. VRNA

Last updated Jun 9, 2026

STX (Seagate Technology plc) and VRNA (Verona Pharma plc) are both stocks. STX operates in Computer Hardware (Technology), while VRNA operates in Biotechnology (Healthcare). At a 0.12 correlation, their price movements are largely independent.

Performance

STX vs. VRNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Seagate Technology plc (STX) and Verona Pharma plc (VRNA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

STX

• 1D: 3.46%
• 1M: 12.03%
• YTD: 218.93%
• 6M: 208.54%
• 1Y: 599.43%
• 3Y*: 149.84%
• 5Y*: 59.24%
• 10Y*: 49.93%

VRNA

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

STX vs. VRNA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
STX Seagate Technology plc	218.93%	225.26%	4.06%	69.12%	-51.42%	87.50%	10.14%	62.14%	-2.90%	4.58%
VRNA Verona Pharma plc	0.00%	130.21%	133.60%	-23.92%	288.84%	-4.00%	21.74%	-40.41%	-18.71%	-12.07%

Correlation

The correlation between STX and VRNA is -0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.01
Correlation (3Y) Calculated over the trailing 3-year period	0.16
Correlation (5Y) Calculated over the trailing 5-year period	0.15
Correlation (All Time) Calculated using the full available price history since Apr 27, 2017	0.12

The correlation between STX and VRNA shifts across timeframes, from -0.01 (1 year) to 0.16 (3 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap STX : $199.90B VRNA : $9.72B
EPS STX : $10.58 VRNA : -$0.69
PS Ratio STX : 17.90 VRNA : 57.97
PB Ratio STX : 182.56 VRNA : 34.92
Total Revenue (TTM) STX : $11.01B VRNA : $167.65M
Gross Profit (TTM) STX : $4.57B VRNA : $159.52M
EBITDA (TTM) STX : $2.59B VRNA : -$40.86M

Return for Risk

STX vs. VRNA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

STX

STX Risk / Return Rank: 99
STX Sharpe Ratio Rank: 100
STX Sortino Ratio Rank: 99
STX Omega Ratio Rank: 98
STX Calmar Ratio Rank: 100
STX Martin Ratio Rank: 100

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

STX vs. VRNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Seagate Technology plc (STX) and Verona Pharma plc (VRNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	STX	VRNA	Difference
Sharpe ratio: Return per unit of total volatility	9.54	—	—
Sortino ratio: Return per unit of downside risk	6.19	—	—
Omega ratio: Gain probability vs. loss probability	1.80	—	—
Calmar ratio: Return relative to maximum drawdown	28.81	—	—
Martin ratio: Return relative to average drawdown	84.36	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	STX	VRNA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	9.54	—	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	1.34	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	1.19	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.53	—	—

Drawdowns

Drawdown Indicators

	STX	VRNA	Difference
Max Drawdown Largest peak-to-trough decline	-88.74%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-21.00%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-40.00%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-56.99%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-56.99%	—	—
Current Drawdown Current decline from peak	-6.80%	—	—
Average Drawdown Average peak-to-trough decline	-26.45%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	7.16%	—	—

Volatility

Volatility by Period

	STX	VRNA	Difference
Volatility (1M) Calculated over the trailing 1-month period	17.98%	—	—
Volatility (6M) Calculated over the trailing 6-month period	49.95%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	63.55%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	44.63%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	42.18%	—	—

Dividends

STX vs. VRNA - Dividend Comparison

STX's dividend yield for the trailing twelve months is around 0.33%, while VRNA has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
STX Seagate Technology plc	0.33%	1.05%	3.27%	3.28%	5.32%	2.40%	4.21%	4.27%	6.53%	6.02%	6.60%	6.14%
VRNA Verona Pharma plc	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

STX vs. VRNA - Profitability Comparison

The chart below illustrates the profitability comparison between Seagate Technology plc and Verona Pharma plc over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

STX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Seagate Technology plc reported a gross profit of 1.45B and revenue of 3.11B. Therefore, the gross margin over that period was 46.5%.

VRNA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Verona Pharma plc reported a gross profit of 71.68M and revenue of 75.14M. Therefore, the gross margin over that period was 95.4%.

STX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Seagate Technology plc reported an operating income of 982.00M and revenue of 3.11B, resulting in an operating margin of 31.6%.

VRNA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Verona Pharma plc reported an operating income of 9.69M and revenue of 75.14M, resulting in an operating margin of 12.9%.

STX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Seagate Technology plc reported a net income of 748.00M and revenue of 3.11B, resulting in a net margin of 24.0%.

VRNA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Verona Pharma plc reported a net income of 8.69M and revenue of 75.14M, resulting in a net margin of 11.6%.

Frequently Asked Questions

Can I hold both STX and VRNA in my portfolio?

STX and VRNA have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.